Operationalization of the ATN classification scheme in preclinical AD: Findings from EPAD V500.0 data release
Silvia Ingala(University of Geneva), Frederik Barkhof(National Hospital for Neurology and Neurosurgery), Lisa Vermunt(Amsterdam Neuroscience), Gaël Chételat(Inserm), Nick C. Fox(NIHR Queen Square Dementia Biomedical Research Unit), Luigi Lorenzini(Amsterdam Neuroscience), Kaj Blennow(Sahlgrenska University Hospital), Viktor Wottschel(University of Geneva), Philip Scheltens(Amsterdam University Medical Centers), Pieter Jelle Visser(Karolinska Institutet), Craig Ritchie(Western General Hospital), José Luís Molinuevo(Pasqual Maragall Foundation), Henk Mutsaerts(Amsterdam Neuroscience), Michael Ewers(German Center for Neurodegenerative Diseases), Ilaria Vergari(Amsterdam Neuroscience), Larissa A Masselink(Amsterdam Neuroscience), Adam Waldman(Royal Society of Edinburgh), Juan Domingo Gispert(Lund University), Graciela Muñiz‐Terrera(University of Edinburgh), Alle Meije Wink(University of Cambridge), Mark E. Schmidt(Janssen (Belgium)), Casper de Boer(Amsterdam Neuroscience), Robin Wolz(Ixico (United Kingdom)), Carol Di Perri(University of Liège)
Cited by 0
Related Papers
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
|Alzheimer s & Dementia|2011|18.9k
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
|Alzheimer s & Dementia|2018|10.4k
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration
|The Lancet Neurology|2013|5.4k
Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment
|Journal of Internal Medicine|2004|5k